You are here
- Home
- Therapy Areas
- Neuroscience
A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, tolerability and Pharmacokinetics of oral AZD2423 after Single Ascending Doses in Healthy Male and Female Volunteers without Childbearing Potentiall
- Disease
- analgaesia
- Drug Name
- AZD2423
- Generic Name
- AZD2423
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jan 18, 1971
- Study Name
- D2600C00001
- Study Id
- D2600C00001
- ClinicalTrials.gov ID
- NCT00940212
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
